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ABSTRACT  
Applications of in situ gel have been used for a variety of drug delivery routes, such as oral, ocular, rectal, vaginal and injection. Characterization of 
in situ gel was determined to ensure that the prepared preparation met the standard and it safe. This review describes every aspects of this novel 
application and characterization of in situ gel preparations, which present the readers an exhaustive detail and might contribute to research and 
development. In the chemical evaluation in situ gel determined the diffusion of the active substance of a compound by measuring its concentration. 
In physical evaluation of isotonic calculated by osmotic pressure, drug release was determined by melting point of the substance polymer, gel 
strength as measured by rheometer, homogenecity test determined by under the light, and stability test with environmental conditions setting. In 
microbiology evaluation determine if the preparations was contaminated or not, also be effective and safe. Ocular irritation studies-Draize Test us 
an animal mice or rabbit and determination of visual appearance, clarity, and pH is required. In situ gels offer the primary requirement of a 
successful controlled release product that is increasing patient compliance. 
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The drug development with new dosage forms has always been 
done to provide effective and easy to use by patients. In addition, the 
presence of new drug preparations may increase bioavailability and 
reduce side effects. One of the discovery is a breakthrough of gel 
preparations with unique characteristics, such as in situ gel. Over the 
last decades, an impressive number of novel temperature, pH, and 
ion induced in situ forming solutions have been described in the 
literature. Each system has its own advantages and drawbacks. The 
choice of particular hydrogels depends on its intrinsic properties 
and investigated therapeutic use.  
In situ gel is a new drug delivery system. When applied, the system is 
carried out in contact with the body, in situ gel will undergo phase 
change to gel due to conditions of pH, electrolytes and temperature 
[1]. In situ gel produces a constant plasma drug profile in the body 
by sustaining the release of drug so it is attached and absorbed in gel 
form and is known to prolong the life of the drug in mucose [2]. 
Another advantage of in situ gel is easy to use, simple manufacturing 
at the factory, and improve both adherence and patient comfort by 
minimizing the frequency of its use [3]. Applications of in situ gel 
have been used for a variety of drug delivery routes, such as oral, 
ocular, rectal, vaginal and injection. 
Oral 
Theophylline, in the form of in situ gels, is administered orally to 
mice and rabbits with gellan gum as sustained release vehicle. The 
process of gel formation occurs in acidic conditions in the stomach. 
The in situ gel forms of theophylline increase bioavailability four to 
fivefold in mice and up to threefold in rabbits [4].  
Ranitidine hydrochloride with a combination of gellan gum results 
in increased viscosity of the preparation as the gellan gum 
concentration increases. Oral in situ gel is sensitive to the 
environment. At the time of administration, in situ gel is present as a 
solution with a low viscosity, but in a sensitive environment, there is 
a change in the conformation of the polymer into gel form. use of in 
situ gel may extend the contact time between the drug and its 
absorption site in the stomach by slowly releasing the drug. 
Therefore, in situ gel is very useful for treating chronic diseases [5]. 
Ocular 
Levofloxacin, as an antibacterial agent, is made in the form of in situ 
gel with additional encapsulation techniques by chitosan 
nanoparticles (CH-NPS). It has proven to be used as an effective 
carrier for treating eye infections [6]. The in situ gel formulation of 
brimonidine tartrate along with carbopol composition polymer 
974P and hidroxy propyl methyl cellulose (HPMC) K4M gives 
sustained release profile so it greatly affects the duration of action of 
the drug and improves the activity of decreasing intraocular 
pressure better than drop preparations to treat glaucoma [7]. 
Rectal 
In situ gel Ibuprofen of solid dispersion in combination with 
poloxamer 407 (thermosensitive), HPMC E5, and sodium alginate 
(mucoadhesive) is known to have a better effect than solid 
suppository when administered to rabbits. It is also produce higher 
plasma peak and bioavailability concentrations. In accordance with 
histopathologic results, it was shown that the use of 15 mg/kg dose 
in situ gel ibuprofen did not produce irritation [8]. 
Nimesulide (2%) was prepared in situ gel preparations with 
addition of HPMC (0.5%) as mucoadhesive polymer, sodium alginate 
(Alg-Na) and poloxamer 407 (18%) as a temperature sensing agent. 
Polyethylene glycol (PEG) is added for gelation temperature 
modification and drug release properties. The addition of 
mucoadhesive polymers aims to address the shortcomings of 
poloxamer 407 with low bioadhesive ability and high permeability 
in water. Combinations all result in acceptable drug release, 
appropriate gel forming temperature, and rectal retention at the 
administration site. The dosage of in situ gel 20 mg/kg does not 
indicate mucosal irritation. Serum concentrations, C (max) and area 
under curve (AUC) Nimesulide increased significantly compared 
with solid suppositories [9]. 
Vaginal 
Clindamycin HCl is prepared in in situ gel form with the addition of 
gellan gum as activated gelling polymer and HPMC (0.1%) ions as 
bioadhesive proven to produce non-irritating, bioadhesive 
preparations with good retention properties. The result of the 
formula had good transparency (refractive index 1.335-1.337), 
International Journal of Applied Pharmaceutics 
ISSN- 0975-7058                               Vol 10, Issue 6, 2018 
Kurniawansyah et al. 
Int J App Pharm, Vol 10, Issue 6, 2018, 34-37 
 
35 
display, clarity, and drug levels of 98.1-101% with accumulated drug 
release reached 98.9% after 12 h of use [10]. 
Treatment of vaginal candidiasis using clotrimazole in situ gel 
formed with mixture of poloxamer 407 and 188, also HPMC K100M 
or E50 is known to produce gel with good retention properties, 
which is the remaining of gel formulations remains in the vaginal 
mucose even after 24 h of application [11]. 
Injection 
Simvastatin as a treatment of osteoporosis was made as biodegradable 
in situ gel with sub-cutaneous administration using chitosan polymer. 
Chitosan was used as biodegradable polymer and beta-glycerol 
phosphate disodium salt hydrate as a buffering agent to reach gelation 
process at pH and body temperature. The results showed the 
development of simvastatin in situ gel, which was administered 
subcutaneously, was effective for the treatment of osteoporosis [12]. 
Doxorubicin (DOX) with the addition of zein was made into in situ gel 
preparation administered through intratumoral injection. Doxorubicin 
is a drug commonly used for the treatment of colorectal cancer but has 
great side effects. The results of the test showed there was an effective 
accumulation of in situ gel DOX as an inhibitory agent in tumors with 
low concentrations of the drug in the blood and normal organs which 
potentially reduce the side effects of the drug [13]. 
Chemical evaluation 
A chemical evaluation is needed to determine which drug or drug 
compound is efficacious to meet the required standards and to 
ensure safety in terms of contaminants [14]. 
Diffusion 
Evaluation of this defuse system using the principle, testing the 
diffusion of the active ingredient of the gel preparation using a 
diffusion cell by measuring the concentration of the active 
ingredient in the receiving fluid at certain intervals [14]. 
Physical evaluation 
Isotonic evaluation 
Tonicity is related to the osmose pressure provided by a solution of a 
dissolved substance or solid [15]. Body fluids or eye fluids provide the 
same osmose pressure with normal osmose saline or 0.9% NaCl. A 
solution with a solute amount/more solute of body fluid/eye fluid has 
a greater osmose pressure and this solution is called a hypertonic 
solution [16]. Conversely, when the number of solutes is less so that 
the lower osmose pressure is called isotonic. Body fluids including eye 
fluids contain a number of solutes which can lower the freezing point 
of a solution of 0.52 °C. Similarly, 0.9% NaCl solution can reduce 
freezing point to 0.52 °C. Therefore 0.9% NaCl solution and body fluids 
are called isotonic. Several ways can be used to calculate the isotonic 
value (tonicity) of a solution, among others: a. Decrease of freezing 
point b. Equivalent NaCl Example of isotonic calculation with frost 
drops given an eyewash solution containing 1% boric acid. For 1% 
boric acid causes a decrease in freezing point of 0.29 °C [17]. Calculate 
the NaCl to be added to obtain an isotonic solution [18]. 
Drug-release 
Evaluation of drug preparation is one drug drug release in the body. 
By knowing the time devastated and the polymer components used 
we can design the drug as per the needs of pharmacotherapy [19]. 
Gel strength 
Based on research, the power of the gel depending on gelling agent 
to the mechanism used in the formula of a material. Gel strength can 
be measured with a rheometer. Placed in an aqueous gel or 
container and then given the pressure slowly so that the tool is 
immersed in the gel. Change the load on the tool can be measured as 
the strength of the gel [20, 21]. 
Homogeneity 
Based on the research, examination of its homogeneity of a material 
can be done by putting the preparation between two glass objects 
then observed particle roughness under light. It aims to find out if 
the entire substance used in the formula is already spread or 
homogeneous [22]. 
Stability studies 
Based on research, testing of stability aimed to know the time of 
storage and the use of a material. The sample is placed in a climatic 
chamber with a temperature of 40 °C and 75% RH for approximately 
one month. After a few months, the sample analyzed associated pH, 
viscocity, clarity, drug content, rheological, and in vitro dissolution 
[23, 24].  
Spreading coefficient 
Spreading coefficient was determined by a device or an apparatus. 
The device consist of a ground glass slide that was fixed on the 
wooden block. Each formulation of emulgel weighting about 2 g was 
placed and study on this ground slide. Gel preparation was then 
sandwiched between this slide and second glass slide having same 
dimension as that of the fixed ground slide. The second glass slide is 
provided with the hook. Weight of 1 g was placed on the top of the 
two slides for 5 min to expel air and to provide a uniform film of gel 
between the two slides. Measured quantity of weight was placed in 
the pan attached to the pulley with the help of hook. The time (in 
seconds) required by the top slide to separate from ground slide was 
noted. A shorter interval indicates better spreading coefficient [25]. 
The result is calculated by using the following formula:  
S =  (M x L)
T
 With: S= Spreading coefficient 
M = Weight tied to upper slide 
L = The length of the glass slides 
T = Time taken to separate the slides. 
Here are the composition of simulated tear fluid 
1. Sodium chloride: 0.670 g 
2. Sodium bicarbonate: 0.200 g 
3. Calcium chloride dihydrate: 0.08 g 
4. Deionized water: 100 g 
Viscosity 
The purpose of this study was to formulate in situ gel that previously 
we know that gels show thixotropic behavior, so that rheological 
research should be done [26]. 
Opthalmic solutions or eye drops that use polymers to increase 
viscosity can improve the bioavalability of the stock. Raising the 
viscosity works to slow the settling of particles and at the same time, 
the viscosity to maintain their suspense [27]. 
The formulation must be done before and after the gelation process 
using a Brookfield viscometer (RVT model) in a small adapter volume 
or a Cone and Platform geometry viscometer (Brookfield RVCP DV-III) 
[28]. Formulations that have viscosities ranging from 5 to 1000 mPas 
in solution form and also after being converted to gel, should be 50 to 
50000 mPas. This test needs to be done at room temperature and 
temperature 37 °C. In situ gel preparations should show pseudoplastic 
flow and Newtonian before and after gelation [29]. The gel 
formulation in situ should be well formulated, so administration to the 
patient is good, especially in ocular administration [30]. 
However, viscosity agents have the disadvantage of making blurred 
vision and leaving residue on the eyelids. Overly high viscosity can 
also cause difficulties in screening used for [27].  
Dissolution  
In vitro release data will provide information about the system under 
test conditions. In vitro test conditions were made as closely as possible 
with in vivo conditions. This study will provide data on residence time, 
and related parameters of pharmacokinetics. These values will help in 
predicting the vivo performance of the dissolution system [31]. 
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Dissolution profile using zero order. First-order Higuchi and 
Korsmeyer Models to ensure pharmacokinetic modeling. The 
Korsmeyer-Peppas equation describes a relationship that describes 
drug release from polumeric to know the mechanism of drug 
release. N-values are used to characterize the release mechanism. 
The value of 0.45 ≤ n corresponds to a Fickian diffusion, whereas a 
value of 0.45<n<0.89 non Fickian transport. If the value of n = 0.89 is 
relational and n>0.89 of case II transport [31]. 
Gel in situ dissolution test was performed using a Franz diffusion 
device and as a phosphate buffer solution (pH 7.4). pH phosphate 
buffer 7.4 will simulate lachrymalfluid. Temperature can be adjusted 
and maintained, 37±0.5 °C with rotation speed at 100 rpm. Take 
samples at intervals of time, then analysis using spectrophotometry 
for drug content [32]. 
Texture analysis 
The purpose of texture analyses is to provide information about 
mechanical properties of samples, namely hardness, compressibility 
and adhesiveness. These properties can be directly correlated with 
Sensory parameters in vivo and therefore, are valuable in the 
development of product with desirable attributes that contribute to 
patient acceptability and compliance [33]. The consistency, firmness 
and cohesiveness of in situ gelling system is assessed by using a 
device called texture profile analyzer. Higher values of adhesiveness 
of gels are needed to maintain intimate contact with mucus surface. 
Texture analysis provides information on mechanical properties of 
gel [34]. 
Determination of visual appearance, clarity, and pH 
Visual appearance were determined by various ways, the first method 
is to visually check the product under fluorescent light with black and 
white as the background in a cabinet that have sufficient light. Second 
method involve checking the pH with a device called pH meter. Each 
formulation was check by dispersing 2.5 g of the formulation in 25 ml 
of purified water. The pH meter must be calibrated before use with 
buffered solution at pH 4 and 7 [35]. And lastly, gelling capacity of 
formulations was evaluated in order to identify the formulations 
suitable for use as in situ gelling systems. Gelling capacity was 
determined by mixing the formulation with simulated tear fluid in the 
proportion 25:7 and examined visually [25]. 
Gelling capacity  
Gelling capacity of formulation is determined by placing a drop of 
the formulation in a vial containing 2.0 ml of freshly prepared 
simulated tear fluid (STF) with the composition of the artificial tear 
fluid is Sodium chloride 0.670 g, Sodium bicarbonate 0.200 g, 
Calcium chloride dihydrate 0.008 g, and purified water q. s. 100 g) 
[36], and time taken for its gelling is noted [1]. It can also be 
determined by placing a drop of formulation in the vial containing 2 
ml of phosphate buffer 7.4. Note the time required to form a gel and 
also note the time taken by the formed gel to dissolve [37]. It can 
also be determined by using visual method the in vitro gelling 
capacities were determined. The colored solutions such as 
(Amaranth dye, Congo red dye and indigo blue dye) can be used by 
dissolving 1g of dye in distilled water and mixed with the 
formulation of in situ gel. The in vitro gelling capacity of the 
formulations were measured by placing 5 ml of gelation solution 
(STF fluid 7.4) in the glass test tube and maintained the temperature 
at 37 °±2 °C. 1 ml of dye solution is taken in the pipette and added 
into the gelation solution (STF fluid 7.4); it immediately converted 
into stiff gel like appearance. The in vitro gelling capacities were 
evaluated by the appearance of stiffness of the gel. And the time 
period for which the gel converted into stiff gel remains as such. 
Further, the color was added to give the visual appearance to the gel. 
Based on the 3 categories the in vitro gelling capacity time period 
was calculated [38]. 
1. (+) Gel forms after few min, disperses rapidly. 
2. (++) Immediately gelation occurs, remains for few h. 




Based on research done by the sterility test, observe the turbidity of 
growth medium and compared with positive and negative control. 
According to the Indian Pharmacopoeia and British Pharmacopoeia, 
microbial growth media used is thioglycolate medium and soy-bean 
digest medium. This testing is done with the technique of aseptic 
work to avoid contamination of the environment. The method used 
is the direct inoculation by way of inoculating the sample into liquid 
media by comparison (1:10) and the media is incubated. Incubation 
time can be done 7–14 d with different temperature; thioglycolate 
medium (30 °–35 °C) and soy-bean digest medium (20 °–25 °C) to 
identify anaerobic and aerobic microbial growth [14, 39-41].  
Antifungal studies 
Based on research associated efficiency testing, antifungal 
performed according to the purpose of pharmacological active 
substances in preparations. On testing, antifungal used saboured 
dextore dissolved in hot water and media was autoclaved for 15 min. 
Insert organism namely Candida albicans and Aspergillus fumigatus 
in media in order and put a sample test with mikropipet and let sit 
for 30 min and then incubated at a temperature of 25 °C for 24 h. 
The diameter of the inhibition zones jamus is measured and 
compared to the positive and negative control [42]. 
Antibacterial activity 
Based on the research by Meshram and Thorat, testing was 
conducted to find out the effectiveness of antibacterial or antibiotic 
active substances used in the preparation of the gel in situ in 
concentrations that can be referred to as antibacterial. Testing is 
done by comparing the results of the growth of bacteria from 
samples with standard antibiotics [43]. 
Ocular irritation studies-draize test 
For the ocular irritation test, Albino rabbit (Newzeland white 
rabbit) are used as test species. One eye is designated the test eye; 
the contralateral eye serves as a matched control and is usually 
left untreated. Single drop approximately 0.04 ml is instilled into 
the lower conjunctival cul-de-sac; normal blinking is allowed, 
although the eyelids can be held together for several seconds after 
instillation. Observations was done at 1, 24, 48, 72 h one week 
after exposure. Ocular changes were graded by a scoring system 
that includes rating any alterations to the eyelids, conjunctiva, 
cornea, and iris [44]. 
Statistic  
The result form experiment mucoadhesive strength and release studies 
were analysed by statistical multivariate test. To get significant 
difference, using various SPSS software and considered significant at 
p<0.05 [1]. 
To test long-term storage conditions can use one-way anova analysis 
of viscosity data using prism with significance value (p>0.05). But 
there is no general rules regarding this statistical test. This test is 
based on the data obtained [45]. 
CONCLUSION 
Evaluation of in situ gel is determined to ensure that the prepared 
preparation meets the standard and is safe. In the chemical 
evaluation in situ gel determined the diffusion of the active 
substance of a compound by measuring its concentration. In physical 
evaluation of isotonic calculated by osmotic pressure, drug release is 
determined by melting point of the substance polymer, gel strength 
as measured by rheometer, homogenecity test determined by test 
under light, and stability test with environmental conditions setting. 
In microbiology evaluation determine if the preparations is 
contaminated or not, also be effective and safe. Ocular irritation 
studies-Draize Test us an animal (mice or et al.) and determination 
of visual appearance, clarity, and pH is required. For analytic test 
about statistic determination with SPSS software with significant 
p<0.05 that means data can be accepted.  
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